Considerations When Choosing a CAR-T Cell Therapy in Lymphoma

(MedPage Today) -- With multiple chimeric antigen receptor (CAR) T cell treatments now approved by the FDA or anticipated to receive approval, such as axicabtagene ciloleucel (axi-cel, Yescarta), tisagenlecleucel (tisa-cel, Kymriah), and brexucabtagene...